LESLIE ROUGEAUX: Open Payments
NPI 1538151774 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 41 payments from 20 companies in 2025. Trend: 2023 $724 · 2024 $630 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $142 |
| PFIZER INC. | 5 | $124 |
| Novo Nordisk Inc | 6 | $121 |
| Dexcom, Inc. | 2 | $71 |
| Amgen Inc. | 3 | $58 |
| HARMONY BIOSCIENCES LLC | 1 | $49 |
| Bausch Health US, LLC | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $39 |
| Alkermes, Inc. | 1 | $34 |
Products named: ELIQUIS, Dexcom G6 Transmitter, WAKIX, WELLBUTRIN, REXULTI, REPATHA, VIVITROL, Korlym.
Industry payments across PA — which companies pay providers there.
